KRYS - Krystal Biotech Inc
IEX Last Trade
194.82
-0.400 -0.205%
Share volume: 202,808
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$195.22
-0.40
-0.21%
Fundamental analysis
15%
Profitability
15%
Dept financing
2%
Liquidity
50%
Performance
10%
Performance
5 Days
-3.20%
1 Month
-3.83%
3 Months
20.74%
6 Months
19.65%
1 Year
53.01%
2 Year
181.36%
Key data
Stock price
$194.82
DAY RANGE
$191.33 - N/A
52 WEEK RANGE
$93.95 - $219.34
52 WEEK CHANGE
$0.55
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/04/2024
Company detail
CEO: Krish S. Krishnan
Region: US
Website: https://www.krystalbio.com/
Employees: 188
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.krystalbio.com/
Employees: 188
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
krystal biotech, inc. is using gene therapy to develop effective and novel treatments for skin diseases. our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases. we work to accomplish that through scientific innovation, operational excellence and believe that “nature operates in the shortest way possible”. (aristotle)
Recent news